Transcripts

EyePoint (EYPT) earnings call transcripts

Earnings call transcripts for EyePoint, Inc., with a summary, the guidance given, and what analysts pressed on.

  • trial results, October 18, 2026

    Management framed LUCIA as a disappointing efficacy miss despite lower treatment burden and anatomic activity, shifting attention to the DME program.

    Oct 19, 2026Negative-0.55